Bernadett Szabados

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 9

Top Topics

Renal Cell Carcinoma

Top Venues

Future oncology (London, England)

Cancer management and research

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Elizabeth Nally, Matthew Young, Vishwani Chauhan, Connor Wells, Bernadett Szabados, Thomas Powles, Francesca Jackson-Spence
Upper Tract Urothelial Carcinoma (UTUC): Prevalence, Impact and Management Challenge. Cancer management and research 16 (2024)
Elizabeth Nally, Matthew Young, Vishwani Chauhan, Connor Wells, Bernadett Szabados, Thomas Powles, Francesca Jackson-Spence
Upper Tract Urothelial Carcinoma (UTUC): Prevalence, Impact and Management Challenge. Cancer management and research 16 (2024)
Naveen S Vasudev, Gemma Ainsworth, Sarah R Brown, Lisa M Pickering, Tom Waddell, Kate Fife, Richard Griffiths, Anand Sharma, Eszter Katona, Helen Howard, Galina Velikova, Anthony Maraveyas, Janet Brown, Carmel Pezaro, Mark Tuthill, Ekaterini Boleti, Amit Bahl, Bernadett Szabados, Rosamonde E Banks, Joanne Brown, Balaji Venugopal, Poulam Manubhai Patel, Ankit Jain, Stefan N Symeonides, Paul D Nathan, Fiona J Collinson, Thomas Powles
Standard Versus Modified Ipilimumab, in Combination With Nivolumab, in Advanced Renal Cell Carcinoma: A Randomized Phase II Trial (PRISM). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Francesca Jackson-Spence, Charlotte Toms, Luke Furtado O'Mahony, Julia Choy, Lucy Flanders, Bernadett Szabados, Thomas Powles
IMvigor011: a study of adjuvant atezolizumab in patients with high-risk MIBC who are ctDNA+ post-surgery. Future oncology (London, England) (2023)
Francesca Jackson-Spence, Charlotte Toms, Luke Furtado O'Mahony, Julia Choy, Lucy Flanders, Bernadett Szabados, Thomas Powles
IMvigor011: a study of adjuvant atezolizumab in patients with high-risk MIBC who are ctDNA+ post-surgery. Future oncology (London, England) (2023)
Francesca Jackson-Spence, Charlotte Toms, Luke Furtado O'Mahony, Julia Choy, Lucy Flanders, Bernadett Szabados, Thomas Powles
IMvigor011: a study of adjuvant atezolizumab in patients with high-risk MIBC who are ctDNA+ post-surgery. Future oncology (London, England) 19 (7) (2023)
Francesca Jackson-Spence, Charlotte Toms, Luke Furtado O'Mahony, Julia Choy, Lucy Flanders, Bernadett Szabados, Thomas Powles
IMvigor011: a study of adjuvant atezolizumab in patients with high-risk MIBC who are ctDNA+ post-surgery. Future oncology (London, England) 19 (7) (2023)
Francesca Jackson-Spence, Charlotte Toms, Luke Furtado O'Mahony, Julia Choy, Lucy Flanders, Bernadett Szabados, Thomas Powles
IMvigor011: a study of adjuvant atezolizumab in patients with high-risk MIBC who are ctDNA+ post-surgery. Future oncology (London, England) 19 (7) (2023)
Francesca Jackson-Spence, Charlotte Toms, Luke Furtado O'Mahony, Julia Choy, Lucy Flanders, Bernadett Szabados, Thomas Powles
IMvigor011: a study of adjuvant atezolizumab in patients with high-risk MIBC who are ctDNA+ post-surgery. Future oncology (London, England) 19 (7) (2023)